Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 31: 423-426, 1985;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adam, A.
Right arrow Articles by Franchimont, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adam, A.
Right arrow Articles by Franchimont, P.

Clinical Chemistry, Vol 31, 423-426, Copyright © 1985 by American Association for Clinical Chemistry

Human kininogens of low and high molecular mass: quantification by radioimmunoassay and determination of reference values

A Adam, A Albert, G Calay, J Closset, J Damas and P Franchimont

Kininogens of low and high molecular mass, highly purified from human plasma, were used to raise antisera in rabbits. To obtain immunologically intact tracers, we labeled the kininogens by the lodogen method, followed by double chromatography, first on Sephadex G50 and then on Sephadex G200 for high-molecular-mass kininogen or on G100 for low-molecular-mass kininogen. Both assays are sensitive, accurate, and reproducible. On an equimolar basis, the high-molecular- mass kininogen cross reacted completely in the determination of low- molecular-mass analyte. Moreover, the radioimmunoassay for the former was highly specific. After optimizing the time and temperature of incubation to provide rapid and reliable results, we determined 95% reference intervals from a large sample of healthy subjects (250 men, 200 women): 109-272 and 69-116 mg/L for the low- and high-molecular- mass kininogens, respectively.


The following articles in journals at HighWire Press have cited this article:


Home page
 HypertensionHome page
S. Houle, G. Molinaro, A. Adam, and F. Marceau
Tissue Kallikrein Actions at the Rabbit Natural or Recombinant Kinin B2 Receptors
Hypertension, March 1, 2003; 41(3): 611 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Cyr, Y. Lepage, C. Blais Jr., N. Gervais, M. Cugno, J.-L. Rouleau, and A. Adam
Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H275 - H283.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. S. Margolius
Kallikreins and Kinins : Some Unanswered Questions About System Characteristics and Roles in Human Disease
Hypertension, August 1, 1995; 26(2): 221 - 229.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Association for Clinical Chemistry.